Both in Pharmaceuticals
Aquestive Therapeutics vs Monopar Therapeutics
Over the past year AQST returned −40.1% and MNPR returned −16.3%; their daily moves had a correlation of 0.22.
AQST −40.1% MNPR −16.3%Growth of $1, one year, split-adjusted
| Metric | AQST | MNPR |
|---|---|---|
| Price | $3.89 | $70.32 |
| Market cap | $488.2M | $472.0M |
| Today | −3.71% | −2.21% |
| 1 month | −12.4% | −9.8% |
| 6 months | −7.4% | +32.1% |
| Year to date | −39.8% | +7.7% |
| 1 year | −40.0% | −16.4% |
| Revenue growth (YoY) | +38.1% | — |
| Gross margin | 70.9% | — |
| Net margin | −165.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.0× | — |
| Net cash | $47.8M | $134.3M |
| Dividend yield | — | — |
| Volatility (60d) | 56.5% | 49.1% |
| Short % of float | 25.6% | 23.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).